aTyr Pharma Historical PE Ratio image   This LIFE PE ratio history page last updated 3/18/2024
aTyr Pharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/14/2024
1.62-0.25-1.00NA
Q3 2023
11/9/2023
1.15-0.20-0.80NA
Q2 2023
8/9/2023
1.96-0.22-0.88NA
Q1 2023
5/9/2023
2.13-0.29-1.16NA
Q4 2022
3/9/2023
1.93-0.26-1.04NA
Q3 2022
11/10/2022
2.38-0.46-1.84NA
Q2 2022
8/15/2022
3.64-0.44-1.76NA
Q1 2022
5/9/2022
3.59-0.44-1.76NA
Q4 2021
3/14/2022
4.75-0.31-1.24NA
Q3 2021
11/10/2021
8.31-0.42-1.68NA
Q2 2021
8/10/2021
4.80-0.64-2.56NA
Q1 2021
5/13/2021
3.62-0.51-2.04NA
Q4 2020
3/23/2021
4.92-0.47-1.88NA
Q3 2020
11/12/2020
3.36-0.68-2.72NA
Q2 2020
8/13/2020
3.91-0.69-2.76NA
Q1 2020
5/12/2020
3.870.251.003.9
Q4 2019
3/26/2020
3.08-1.54-6.16NA
Q3 2019
11/14/2019
3.63-1.47-5.88NA
Q2 2019
8/14/2019
2.80-1.80-7.20NA
Q1 2019
5/13/2019
7.43-2.52-10.08NA
Q4 2018
3/25/2019
7.07-2.94-11.76NA
Q3 2018
11/13/2018
7.73-3.36-13.44NA
Q2 2018
8/14/2018
9.24-4.90-19.60NA
Q1 2018
5/15/2018
18.90-5.04-20.16NA
Q4 2017
3/19/2018
42.00-5.46-21.84NA
Q3 2017
11/14/2017
51.80-6.02-24.08NA
Q2 2017
8/14/2017
45.50-7.14-28.56NA
Q1 2017
5/11/2017
43.40-7.84-31.36NA
Q4 2016
3/16/2017
53.20-7.42-29.68NA
Q3 2016
11/14/2016
49.00-8.12-32.48NA
Q3 2013
11/5/2013
1055.4614.2857.1218.5
Q2 2013
7/31/2013
1044.4013.7254.8819.0
Q1 2013
5/2/2013
1030.8214.9859.9217.2
Q4 2012
2/4/2013
882.2815.5462.1614.2
Q3 2012
11/1/2012
703.7812.8851.5213.7
Q2 2012
7/31/2012
614.3213.4453.7611.4
aTyr Pharma PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/14/2024
1.62-0.25-0.96NA
Q3 2023
11/9/2023
1.15-0.20-0.97NA
Q2 2023
8/9/2023
1.96-0.22-1.23NA
Q1 2023
5/9/2023
2.13-0.29-1.45NA
Q4 2022
3/9/2023
1.93-0.26-1.60NA
Q3 2022
11/10/2022
2.38-0.46-1.65NA
Q2 2022
8/15/2022
3.64-0.44-1.61NA
Q1 2022
5/9/2022
3.59-0.44-1.81NA
Q4 2021
3/14/2022
4.75-0.31-1.88NA
Q3 2021
11/10/2021
8.31-0.42-2.04NA
Q2 2021
8/10/2021
4.80-0.64-2.30NA
Q1 2021
5/13/2021
3.62-0.51-2.35NA
Q4 2020
3/23/2021
4.92-0.47-1.59NA
Q3 2020
11/12/2020
3.36-0.68-2.66NA
Q2 2020
8/13/2020
3.91-0.69-3.45NA
Q1 2020
5/12/2020
3.870.25-4.56NA
Q4 2019
3/26/2020
3.08-1.54-7.33NA
Q3 2019
11/14/2019
3.63-1.47-8.73NA
Q2 2019
8/14/2019
2.80-1.80-10.62NA
Q1 2019
5/13/2019
7.43-2.52-13.72NA
Q4 2018
3/25/2019
7.07-2.94-16.24NA
Q3 2018
11/13/2018
7.73-3.36-18.76NA
Q2 2018
8/14/2018
9.24-4.90-21.42NA
Q1 2018
5/15/2018
18.90-5.04-23.66NA
Q4 2017
3/19/2018
42.00-5.46-26.46NA
Q3 2017
11/14/2017
51.80-6.02-28.42NA
Q2 2017
8/14/2017
45.50-7.14-30.52NA
Q1 2017
5/11/2017
43.40-7.84-9.10NA
Q4 2016
3/16/2017
53.20-7.4212.464.3
Q3 2016
11/14/2016
49.00-8.1234.861.4
Q3 2013
11/5/2013
1055.4614.2858.5218.0
Q2 2013
7/31/2013
1044.4013.7257.1218.3
Q1 2013
5/2/2013
1030.8214.9856.8418.1
Q4 2012
2/4/2013
882.2815.54NANA
Q3 2012
11/1/2012
703.7812.88NANA
Q2 2012
7/31/2012
614.3213.44NANA
Quotes delayed 20 minutes

Email EnvelopeFree LIFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
aTyr Pharma (LIFE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LIXT PE Ratio History
LJPC PE Ratio History
LLY PE Ratio History
LMAT PE Ratio History
LMNX PE Ratio History
LNSR PE Ratio History
LNTH PE Ratio History
LOGC PE Ratio History
LPCN PE Ratio History
LPTX PE Ratio History
How should the LIFE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like aTyr Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LIFE Historical PE Ratio page.

What is the average historical PE for LIFE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LIFE historical PE ratio using the annualized quarterly earnings method works out to 14.0.

What is the average historical PE for LIFE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LIFE historical PE ratio using the TTM earnings method works out to 12.0.

On this page we presented the aTyr Pharma Historical PE Ratio information for aTyr Pharma' stock. The average LIFE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 14.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LIFE historical PE based on this TTM earnings result method is 12.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LIFE historical PE result, against the recent PE: when this page was posted on 3/15/2024, the most recent closing price for LIFE had been 1.99, and the most recent quarterly earnings result, annualized, was 1. Meanwhile, the most recent TTM earnings summed to 12.46. From these numbers, we calculate the recent LIFE PE on 3/15/2024 based on annualized quarterly EPS was 2.0. Based on LIFE's history, that recent PE is low relative to the historical average, with the recent PE 85.7% lower than the historical average PE across our data set for aTyr Pharma. Looking at the recent LIFE PE on 3/15/2024 based on TTM EPS, we calculate the ratio at 0.2. Based on LIFE's history, that recent PE is low relative to the historical average, with the recent PE 98.3% lower than the average PE across our aTyr Pharma data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on LIFE or any other given stock, valuation analysis for LIFE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate aTyr Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LIFE. Thanks for visiting, and the next time you need to research LIFE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: EFX RSI, GLD YTD Return, NPY Historical Stock Prices.

 

aTyr Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.